exposure to a gadolinium-based contrast agent cannot be documented in all patients developing NSF
Denver (PRWEB) October 21, 2008
LegalView, the number one resource for everything and anything legal on the Web, recently re-launched its Nephrogenic Systemic Fibrosis information portal. The newly updated portal provides resources for victims as well as causes and potential treatments for the condition, which is a relatively new illness that has been linked to the use of gadolinium dyes associated with magnetic resonance imaging/magnetic resonance angiography (MRI/MRA). While the disease is still being researched, it seems to affect a slim population of those suffering from kidney disease, who receive gadolinium dyes during MRI/MRA procedures. Scientists are still determining how to better administer this type of a procedure among kidney disease patients, but have found that the only alternative is to evaluate each patient prior to administering gadolinium dyes.
Patients who suffer from this severely debilitating condition are advised to consult an NSF lawyer for a free legal consultation on developing any potential NSF lawsuit. Because of certain NSF symptoms, which can cause a patient's skin to thicken and swell, it is important that an NSF victim develop litigation that may allow them to retrieve monetary compensation to help pay for extremely costly medical bills to treat the condition.
NSF was first diagnosed in 1997 in California, according to a study published in a December 2006 issue of European Radiology. The condition was first thought to only affect the skin, but was found to also have damaging risks to organs including the liver, lungs, heart and muscles. Nephrogenic Systemic Fibrosis symptoms include red or darkened patches on the skin that may include plaques or papules; burning, itching and pain on the skin; swelling, tightening and thickening of the skin; and swelling of the joints to the point that they may not be able to move or bend limbs causing a moderate form of paralysis.
The European Radiology article noted that as of 2006, no patients with normal kidney function have developed NSF and at least 150 patients exposed to a gadodiamide, also Gd-based contrast dyes, developed the condition. Even though the dye has been strongly linked to the development of NSF, the U.S. Food and Drug Administration (FDA) has not been recalled as, "exposure to a gadolinium-based contrast agent cannot be documented in all patients developing NSF," according to the article. However, NSF patients should still consider contacting an NSF law firm that can provide assistance in locating and consulting with an experienced NSF attorney about developing litigation. An Nephrogenic Systemic Fibrosis lawsuit can potentially provide monetary compensation to pay for NSF treatments and physical therapy.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.LegalView.com/.